Circadian disruption and dysregulated BMAL1 signaling impair oocyte quality and may negatively impact assisted reproduction outcomes
The paper reviews evidence that BMAL1, a core circadian transcription factor, regulates ovarian physiology including folliculogenesis, steroidogenesis, mitochondrial activity, oxidative balance, and meiotic spindle organization. Dysregulated BMAL1 signaling is associated with compromised oocyte quality and early embryo development, and clinical findings suggest circadian disruption, sleep problems, obesity, ageing, and metabolic dysfunction may influence IVF outcomes.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Circadian disruption and dysregulated BMAL1 signaling impair oocyte quality and may negatively impact assisted reproduction outcomes The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Circadian disruption and dysregulated BMAL1 signaling impair oocyte quality and may negatively impact assisted reproduction outcomes
This conclusion is most relevant to: Ovarian follicles and oocytes (from experimental and clinical studies).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸BMAL1-Mediated Circadian Regulation of Oocyte Quality and IVF Outcomes. (Genes, 2026) —
How It Works
The proposed biological pathway:
- ▸BMAL1 regulates circadian gene expression in ovarian cells
- ▸Disrupted BMAL1 signaling leads to mitochondrial dysfunction and elevated oxidative stress
- ▸This causes irregularities in meiotic spindle organization and compromised folliculogenesis
- ▸Result: reduced oocyte quality and impaired early embryo development
Who Might Benefit
Evidence fit by population:
- ▸Ovarian follicles and oocytes (from experimental and clinical studies)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Abstract does not provide quantitative data or effect sizes
- ▸Review article, not a primary experimental study, so causal inference is limited
- ▸Potential publication bias in cited studies
Frequently Asked Questions
What is BMAL1?▼
BMAL1 (Brain and Muscle ARNT-like protein 1) is a core transcription factor in the circadian clock that regulates daily rhythms in gene expression, including in ovarian tissues.
How does circadian disruption affect fertility?▼
Circadian disruption can impair BMAL1 signaling, leading to mitochondrial dysfunction, oxidative stress, and meiotic spindle abnormalities, which collectively reduce oocyte quality and may lower IVF success rates.
Can improving sleep or circadian rhythms improve IVF outcomes?▼
The paper suggests that circadian disruption and sleep problems may negatively impact assisted reproduction, implying that optimizing circadian rhythms could be beneficial, but direct interventional evidence is not provided in this abstract.
What are the clinical implications for women undergoing IVF?▼
Clinicians may consider assessing and addressing circadian disruption, sleep quality, and metabolic factors in patients to potentially improve oocyte quality and IVF outcomes, though more research is needed.
References
- 1.Voros C, Zagorianakou N, Makrydimas S, Chatzinikolaou F, Papadimas G, Koulakmanidis AM, Thomakos N, Antsaklis P, Daskalakis G, Makrydimas G. “BMAL1-Mediated Circadian Regulation of Oocyte Quality and IVF Outcomes..” Genes, 2026. PMID: 42650173 DOI: 10.3390/genes17080981